|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.40 HKD | -1.81% |
|
-10.17% | -12.38% |
| 04-29 | Abbisko Completes HK$523 Million Share Offering | MT |
| 04-23 | Abbisko Therapeutics Showcases Six Research Advances Highlighting Pan-KRAS, 4th Generation EGFR, And Synthetic Lethality Approaches | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBISKO CAYMAN LIMITED | Bio Therapeutic Drugs | -1.81% | -10.17% | -12.38% | +45.59% | - | 1.06B |  |  | |
- Stock Market
- Equities
- 2256 Stock
- Charts Abbisko Cayman Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition